Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Trained Immunity by Dual-pathway Inhibition in Coronary Artery Disease [Phase 4]
Phase 4 trial update exploring trained immunity via dual-pathway inhibition in patients with coronary artery disease; current status unknown…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Metformin in Diabetic Patients Undergoing Coronary Angiography [Phase 4]
A Phase 4 clinical trial evaluating metformin in diabetic patients undergoing coronary angiography is listed with an unknown status and seve…
-
FDA approval · 2022-04-11FDA Approved: REGADENOSON — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s generic Regadenoson for use as a pharmacologic stress agent in myocardial perfusion imaging to evaluate for coro…
-
FDA approval · 2022-04-11FDA Approved: REGADENOSON — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for Regadenoson from Dr. Reddy's Laboratories Inc. as a generic product for pharmacologic stress testi…
-
FDA approval · 2022-04-11FDA Approved: REGADENOSON — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original (ANDA) application for Regadenoson, a generic pharmacologic stress agent used for myocardial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Evaluation of a Web-based Intervention to Promote Physical Activity in Patients With Heart Disease. [Phase 3]
Phase 3 trial update evaluating a web-based intervention to promote physical activity in patients with coronary artery disease.
-
CLINICAL_TRIALS research · 2022-03-24Clinical Trial Update: Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease [Phase 4]
A Phase 4 randomized trial update evaluating differential therapeutic responses in symptomatic patients with non-obstructive coronary artery…
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial [Phase 4]
Phase 4 randomized trial evaluating collagen-thrombin matrix during cardiac surgery in coronary artery disease patients.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Colchicine Use for Primary Prevention of Coronary Artery Disease [Phase 3]
Phase 3 clinical trial investigating colchicine for primary prevention of coronary artery disease.
-
FDA approval · 2022-03-09FDA Approved: MYOVIEW — Supplemental Application (Medi-Physics Inc. dba GE Healthcare)
FDA approved a supplemental application for MYOVIEW (tetrofosmin) by Medi-Physics Inc. dba GE Healthcare, authorizing an updated use of the …
-
FDA approval · 2022-03-07FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel [Phase 4]
Phase 4 trial updating platelet aggregation and adenosine levels in patients taking ticagrelor vs prasugrel.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396) [Phase 3]
Phase 3 trial comparing ezetimibe plus atorvastatin versus atorvastatin alone in untreated primary hypercholesterolemia with coronary heart …
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Simultaneous Assessment of FFR and SPECT [NA]
Clinical trial update noting termination of a study assessing FFR and SPECT for coronary artery disease with results posted.
-
CLINICAL_TRIALS research · 2022-01-28Clinical Trial Update: Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease [Phase 4]
A Phase 4 trial evaluating how chronic kidney disease affects the effects of ticagrelor in patients with diabetes and coronary artery diseas…
-
FDA approval · 2022-01-26FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for Edenbridge Pharmaceuticals' generic Isosorbide Mononitrate.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly [NA]
The trial evaluated implantable cardioverter-defibrillator implantation in elderly patients with cardiomyopathy and coronary artery disease,…
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease [NA]
Final results from a completed clinical trial comparing fractional flow reserve-guided percutaneous coronary intervention to coronary artery…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) [NA]
Post-approval study update for the RESOLUTE ONYX bifurcation cohort; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft [Phase 4]
Phase 4 trial comparing dexmedetomidine and meperidine for prevention of shivering after coronary artery bypass grafting.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT [NA]
Clinical trial update for the COBRA PZF coronary stent completed with results posted in 2021.
-
FDA approval · 2021-12-21FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited. The action confirms approva…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: XIENCE 28 USA Study [NA]
Clinical trial update for XIENCE 28 USA study has completed with results posted in December 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Effect of Pre-op NRT on Peri-operative Complications and Long-term Abstinence: A Pilot Trial in Patients Undergoing CABG Surgery [Phase 4]
Pilot Phase 4 trial evaluating pre-operative nicotine replacement therapy to reduce peri-operative complications and support long-term smoki…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Imaging of Coronary Plaques in Participants Treated With Evolocumab [Phase 3]
Phase 3 trial update evaluating imaging of coronary plaques in participants treated with evolocumab (AMG 232) in coronary artery disease.